Hepion Pharmaceuticals Inc (HEPA)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current HEPA market cap is 1.13M. The company's latest EPS is USD -7.0312 and P/E is -0.02.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.67M | -10.41M | -5.18M | -8.5M | -4.46M |
| Net Income | -10.53M | -11.06M | -2.85M | -3.93M | -4.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.77M | -20.15M | -30.4M | -45.49M | -48.45M |
| Net Income | -12.16M | -20.36M | -32.72M | -45.34M | -48.93M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 25M | 18.09M | 15.99M | 6.01M | 3.72M |
| Total Liabilities | 8.84M | 10.81M | 8.47M | 2.45M | 4.12M |
| Total Equity | 16.16M | 7.28M | 7.52M | 3.56M | -406k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 20.43M | 48.65M | 103.55M | 60.24M | 18.09M |
| Total Liabilities | 4.25M | 8.13M | 10.56M | 10.39M | 10.81M |
| Total Equity | 16.19M | 40.52M | 93M | 49.86M | 7.28M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -31.89M | -40.89M | -3.62M | -14.55M | -17.06M |
| Investing | -14k | -14k | N/A | N/A | -600k |
| Financing | N/A | 4.5M | 1.85M | 1.85M | 4.35M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.57M | -16.17M | -31.22M | -34.96M | -40.89M |
| Investing | -51k | -86k | -131k | -14k | -14k |
| Financing | 18.71M | 43.06M | 81.98M | -5.14M | 4.5M |
| Market Cap | 1.13M |
| Price to Earnings Ratio | -0.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.08 |
| Price to Book Ratio | 0.15 |
| Dividend Yield | - |
| Shares Outstanding | 6.96M |
| Average Volume (1 week) | 6.42M |
| Average Volume (1 Month) | 29.04M |
| 52 Week Change | -93.29% |
| 52 Week High | 3.33 |
| 52 Week Low | 0.121 |
| Spread (Intraday) | 0 (1.54%) |
| Company Name | Hepion Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.hepion.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
